It has been associated with the dysregulation of ADAM17-mediated erbB/EGF receptor signalling in Kras-mutant lung cancer via the phosphorylation of iRhom2, the recruitment of phospho-binding proteins, and the shedding of erbB ligands [39]. This evidence concerns the gene EGFR and lung carcinoma.